MAYNE PHARMA GROUP LIMITED — Capital/Financing Update 2012

Nov 14, 2012

==> picture [199 x 121] intentionally omitted <==

15 November 2012

Manager, Company Announcements ASX Limited Rialto Towers Level 45, 525 Collins Street MELBOURNE VIC 3000

Dear Sir/Madam

Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth)

This notice is given by Mayne Pharma Group Limited ACN 115 832 963( Mayne Pharma ) under section 708A(5)(e) of the Corporations Act 2001 (Cth) ( Corporations Act ).

Mayne Pharma has today issued 17,495,422 fully paid ordinary shares in Mayne Pharma ( Placement Shares ) to certain shareholders of Metrics, Inc. under the placement component of the capital raising announced by Mayne Pharma on 4 October 2012 and under additional placements.

Mayne Pharma advises that:

• (a) the Placement Shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act;

• (b) this notice is being given under section 708A(5)(e) of the Corporations Act;

• (c) as at the date of this notice, Mayne Pharma has complied with:

  • (i) the provisions of Chapter 2M of the Corporations Act as they apply to Mayne Pharma; and

  • (ii) section 674 of the Corporations Act; and

• (d) as at the date of this notice, there is no excluded information of the type referred to in sections 708A(7) and 708A(8) of the Corporations Act.

Yours sincerely

==> picture [152 x 34] intentionally omitted <==

Mark Cansdale Company Secretary

Mayne Pharma Group Limited ABN | 76 115 832 963

a | Level 14, 474 Flinders St, Melbourne Victoria 3000, Australia t | +61 3 8614 7777 f | +61 3 9614 7022 | www.maynepharma.com